 | • レポートコード：MRC2-11QY04257 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は薬物動態学のグローバル市場について調査・分析したレポートです。種類別（非コンパートメント方式、コンパートメント方式）市場規模、用途別（腫瘍、心血管疾患、感染症、自己免疫疾患、呼吸器疾患、神経疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別薬物動態学の競争状況、市場シェア ・世界の薬物動態学市場：種類別市場規模 2015年-2020年（非コンパートメント方式、コンパートメント方式） ・世界の薬物動態学市場：種類別市場規模予測 2021年-2026年（非コンパートメント方式、コンパートメント方式） ・世界の薬物動態学市場：用途別市場規模 2015年-2020年（腫瘍、心血管疾患、感染症、自己免疫疾患、呼吸器疾患、神経疾患、その他） ・世界の薬物動態学市場：用途別市場規模予測 2021年-2026年（腫瘍、心血管疾患、感染症、自己免疫疾患、呼吸器疾患、神経疾患、その他） ・北米の薬物動態学市場分析：米国、カナダ ・ヨーロッパの薬物動態学市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの薬物動態学市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の薬物動態学市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの薬物動態学市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Charles River Laboratories、Covance、Cyprotex、Drumetix Laboratories、Eurofins Scientific、GVK Biosciences、LGC、Parexel、Pharmoptima、TCG Lifesciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pharmacokinetics is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism.
Pharmacokinetics describes how the body affects a specific chemical after administration through the mechanisms of absorption and distribution, as well as the metabolic changes of the substance in the body, and the effects and routes of excretion of the metabolites of the drug.
Market Analysis and Insights: Global Pharmacokinetics Market
The global Pharmacokinetics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pharmacokinetics Scope and Market Size
Pharmacokinetics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacokinetics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Charles River Laboratories
Covance
Cyprotex
Drumetix Laboratories
Eurofins Scientific
GVK Biosciences
LGC
Parexel
Pharmoptima
TCG Lifesciences
Market segment by Type, the product can be split into
Noncompartmental Methods
Compartmental Methods
Market segment by Application, split into
Oncology
Cardiovascular Diseases
Infectious Diseases
Autoimmune Diseases
Respiratory Disorders
Neurological Disorders
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmacokinetics Revenue
1.4 Market by Type
1.4.1 Global Pharmacokinetics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Noncompartmental Methods
1.4.3 Compartmental Methods
1.5 Market by Application
1.5.1 Global Pharmacokinetics Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Cardiovascular Diseases
1.5.4 Infectious Diseases
1.5.5 Autoimmune Diseases
1.5.6 Respiratory Disorders
1.5.7 Neurological Disorders
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Market Perspective (2015-2026)
2.2 Global Pharmacokinetics Growth Trends by Regions
2.2.1 Pharmacokinetics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmacokinetics Historic Market Share by Regions (2015-2020)
2.2.3 Pharmacokinetics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmacokinetics Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmacokinetics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Players by Market Size
3.1.1 Global Top Pharmacokinetics Players by Revenue (2015-2020)
3.1.2 Global Pharmacokinetics Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmacokinetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmacokinetics Market Concentration Ratio
3.2.1 Global Pharmacokinetics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Revenue in 2019
3.3 Pharmacokinetics Key Players Head office and Area Served
3.4 Key Players Pharmacokinetics Product Solution and Service
3.5 Date of Enter into Pharmacokinetics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pharmacokinetics Historic Market Size by Type (2015-2020)
4.2 Global Pharmacokinetics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pharmacokinetics Market Size by Application (2015-2020)
5.2 Global Pharmacokinetics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pharmacokinetics Market Size (2015-2020)
6.2 Pharmacokinetics Key Players in North America (2019-2020)
6.3 North America Pharmacokinetics Market Size by Type (2015-2020)
6.4 North America Pharmacokinetics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pharmacokinetics Market Size (2015-2020)
7.2 Pharmacokinetics Key Players in Europe (2019-2020)
7.3 Europe Pharmacokinetics Market Size by Type (2015-2020)
7.4 Europe Pharmacokinetics Market Size by Application (2015-2020)
8 China
8.1 China Pharmacokinetics Market Size (2015-2020)
8.2 Pharmacokinetics Key Players in China (2019-2020)
8.3 China Pharmacokinetics Market Size by Type (2015-2020)
8.4 China Pharmacokinetics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pharmacokinetics Market Size (2015-2020)
9.2 Pharmacokinetics Key Players in Japan (2019-2020)
9.3 Japan Pharmacokinetics Market Size by Type (2015-2020)
9.4 Japan Pharmacokinetics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pharmacokinetics Market Size (2015-2020)
10.2 Pharmacokinetics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmacokinetics Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmacokinetics Market Size by Application (2015-2020)
11 India
11.1 India Pharmacokinetics Market Size (2015-2020)
11.2 Pharmacokinetics Key Players in India (2019-2020)
11.3 India Pharmacokinetics Market Size by Type (2015-2020)
11.4 India Pharmacokinetics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pharmacokinetics Market Size (2015-2020)
12.2 Pharmacokinetics Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmacokinetics Market Size by Type (2015-2020)
12.4 Central & South America Pharmacokinetics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Charles River Laboratories
13.1.1 Charles River Laboratories Company Details
13.1.2 Charles River Laboratories Business Overview
13.1.3 Charles River Laboratories Pharmacokinetics Introduction
13.1.4 Charles River Laboratories Revenue in Pharmacokinetics Business (2015-2020))
13.1.5 Charles River Laboratories Recent Development
13.2 Covance
13.2.1 Covance Company Details
13.2.2 Covance Business Overview
13.2.3 Covance Pharmacokinetics Introduction
13.2.4 Covance Revenue in Pharmacokinetics Business (2015-2020)
13.2.5 Covance Recent Development
13.3 Cyprotex
13.3.1 Cyprotex Company Details
13.3.2 Cyprotex Business Overview
13.3.3 Cyprotex Pharmacokinetics Introduction
13.3.4 Cyprotex Revenue in Pharmacokinetics Business (2015-2020)
13.3.5 Cyprotex Recent Development
13.4 Drumetix Laboratories
13.4.1 Drumetix Laboratories Company Details
13.4.2 Drumetix Laboratories Business Overview
13.4.3 Drumetix Laboratories Pharmacokinetics Introduction
13.4.4 Drumetix Laboratories Revenue in Pharmacokinetics Business (2015-2020)
13.4.5 Drumetix Laboratories Recent Development
13.5 Eurofins Scientific
13.5.1 Eurofins Scientific Company Details
13.5.2 Eurofins Scientific Business Overview
13.5.3 Eurofins Scientific Pharmacokinetics Introduction
13.5.4 Eurofins Scientific Revenue in Pharmacokinetics Business (2015-2020)
13.5.5 Eurofins Scientific Recent Development
13.6 GVK Biosciences
13.6.1 GVK Biosciences Company Details
13.6.2 GVK Biosciences Business Overview
13.6.3 GVK Biosciences Pharmacokinetics Introduction
13.6.4 GVK Biosciences Revenue in Pharmacokinetics Business (2015-2020)
13.6.5 GVK Biosciences Recent Development
13.7 LGC
13.7.1 LGC Company Details
13.7.2 LGC Business Overview
13.7.3 LGC Pharmacokinetics Introduction
13.7.4 LGC Revenue in Pharmacokinetics Business (2015-2020)
13.7.5 LGC Recent Development
13.8 Parexel
13.8.1 Parexel Company Details
13.8.2 Parexel Business Overview
13.8.3 Parexel Pharmacokinetics Introduction
13.8.4 Parexel Revenue in Pharmacokinetics Business (2015-2020)
13.8.5 Parexel Recent Development
13.9 Pharmoptima
13.9.1 Pharmoptima Company Details
13.9.2 Pharmoptima Business Overview
13.9.3 Pharmoptima Pharmacokinetics Introduction
13.9.4 Pharmoptima Revenue in Pharmacokinetics Business (2015-2020)
13.9.5 Pharmoptima Recent Development
13.10 TCG Lifesciences
13.10.1 TCG Lifesciences Company Details
13.10.2 TCG Lifesciences Business Overview
13.10.3 TCG Lifesciences Pharmacokinetics Introduction
13.10.4 TCG Lifesciences Revenue in Pharmacokinetics Business (2015-2020)
13.10.5 TCG Lifesciences Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pharmacokinetics Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmacokinetics Revenue
Table 3. Ranking of Global Top Pharmacokinetics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmacokinetics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Noncompartmental Methods
Table 6. Key Players of Compartmental Methods
Table 7. Global Pharmacokinetics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pharmacokinetics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pharmacokinetics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pharmacokinetics Market Share by Regions (2015-2020)
Table 11. Global Pharmacokinetics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pharmacokinetics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Pharmacokinetics Market Growth Strategy
Table 17. Main Points Interviewed from Key Pharmacokinetics Players
Table 18. Global Pharmacokinetics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Pharmacokinetics Market Share by Players (2015-2020)
Table 20. Global Top Pharmacokinetics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacokinetics as of 2019)
Table 21. Global Pharmacokinetics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pharmacokinetics Product Solution and Service
Table 24. Date of Enter into Pharmacokinetics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pharmacokinetics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Pharmacokinetics Market Size Share by Type (2015-2020)
Table 28. Global Pharmacokinetics Revenue Market Share by Type (2021-2026)
Table 29. Global Pharmacokinetics Market Size Share by Application (2015-2020)
Table 30. Global Pharmacokinetics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Pharmacokinetics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Pharmacokinetics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Pharmacokinetics Market Share (2019-2020)
Table 34. North America Pharmacokinetics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Pharmacokinetics Market Share by Type (2015-2020)
Table 36. North America Pharmacokinetics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Pharmacokinetics Market Share by Application (2015-2020)
Table 38. Europe Key Players Pharmacokinetics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Pharmacokinetics Market Share (2019-2020)
Table 40. Europe Pharmacokinetics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Pharmacokinetics Market Share by Type (2015-2020)
Table 42. Europe Pharmacokinetics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Pharmacokinetics Market Share by Application (2015-2020)
Table 44. China Key Players Pharmacokinetics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Pharmacokinetics Market Share (2019-2020)
Table 46. China Pharmacokinetics Market Size by Type (2015-2020) (Million US$)
Table 47. China Pharmacokinetics Market Share by Type (2015-2020)
Table 48. China Pharmacokinetics Market Size by Application (2015-2020) (Million US$)
Table 49. China Pharmacokinetics Market Share by Application (2015-2020)
Table 50. Japan Key Players Pharmacokinetics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Pharmacokinetics Market Share (2019-2020)
Table 52. Japan Pharmacokinetics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Pharmacokinetics Market Share by Type (2015-2020)
Table 54. Japan Pharmacokinetics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Pharmacokinetics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Pharmacokinetics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Pharmacokinetics Market Share (2019-2020)
Table 58. Southeast Asia Pharmacokinetics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Pharmacokinetics Market Share by Type (2015-2020)
Table 60. Southeast Asia Pharmacokinetics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Pharmacokinetics Market Share by Application (2015-2020)
Table 62. India Key Players Pharmacokinetics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Pharmacokinetics Market Share (2019-2020)
Table 64. India Pharmacokinetics Market Size by Type (2015-2020) (Million US$)
Table 65. India Pharmacokinetics Market Share by Type (2015-2020)
Table 66. India Pharmacokinetics Market Size by Application (2015-2020) (Million US$)
Table 67. India Pharmacokinetics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Pharmacokinetics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Pharmacokinetics Market Share (2019-2020)
Table 70. Central & South America Pharmacokinetics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Pharmacokinetics Market Share by Type (2015-2020)
Table 72. Central & South America Pharmacokinetics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Pharmacokinetics Market Share by Application (2015-2020)
Table 74. Charles River Laboratories Company Details
Table 75. Charles River Laboratories Business Overview
Table 76. Charles River Laboratories Product
Table 77. Charles River Laboratories Revenue in Pharmacokinetics Business (2015-2020) (Million US$)
Table 78. Charles River Laboratories Recent Development
Table 79. Covance Company Details
Table 80. Covance Business Overview
Table 81. Covance Product
Table 82. Covance Revenue in Pharmacokinetics Business (2015-2020) (Million US$)
Table 83. Covance Recent Development
Table 84. Cyprotex Company Details
Table 85. Cyprotex Business Overview
Table 86. Cyprotex Product
Table 87. Cyprotex Revenue in Pharmacokinetics Business (2015-2020) (Million US$)
Table 88. Cyprotex Recent Development
Table 89. Drumetix Laboratories Company Details
Table 90. Drumetix Laboratories Business Overview
Table 91. Drumetix Laboratories Product
Table 92. Drumetix Laboratories Revenue in Pharmacokinetics Business (2015-2020) (Million US$)
Table 93. Drumetix Laboratories Recent Development
Table 94. Eurofins Scientific Company Details
Table 95. Eurofins Scientific Business Overview
Table 96. Eurofins Scientific Product
Table 97. Eurofins Scientific Revenue in Pharmacokinetics Business (2015-2020) (Million US$)
Table 98. Eurofins Scientific Recent Development
Table 99. GVK Biosciences Company Details
Table 100. GVK Biosciences Business Overview
Table 101. GVK Biosciences Product
Table 102. GVK Biosciences Revenue in Pharmacokinetics Business (2015-2020) (Million US$)
Table 103. GVK Biosciences Recent Development
Table 104. LGC Company Details
Table 105. LGC Business Overview
Table 106. LGC Product
Table 107. LGC Revenue in Pharmacokinetics Business (2015-2020) (Million US$)
Table 108. LGC Recent Development
Table 109. Parexel Business Overview
Table 110. Parexel Product
Table 111. Parexel Company Details
Table 112. Parexel Revenue in Pharmacokinetics Business (2015-2020) (Million US$)
Table 113. Parexel Recent Development
Table 114. Pharmoptima Company Details
Table 115. Pharmoptima Business Overview
Table 116. Pharmoptima Product
Table 117. Pharmoptima Revenue in Pharmacokinetics Business (2015-2020) (Million US$)
Table 118. Pharmoptima Recent Development
Table 119. TCG Lifesciences Company Details
Table 120. TCG Lifesciences Business Overview
Table 121. TCG Lifesciences Product
Table 122. TCG Lifesciences Revenue in Pharmacokinetics Business (2015-2020) (Million US$)
Table 123. TCG Lifesciences Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacokinetics Market Share by Type: 2020 VS 2026
Figure 2. Noncompartmental Methods Features
Figure 3. Compartmental Methods Features
Figure 4. Global Pharmacokinetics Market Share by Application: 2020 VS 2026
Figure 5. Oncology Case Studies
Figure 6. Cardiovascular Diseases Case Studies
Figure 7. Infectious Diseases Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Respiratory Disorders Case Studies
Figure 10. Neurological Disorders Case Studies
Figure 11. Others Case Studies
Figure 12. Pharmacokinetics Report Years Considered
Figure 13. Global Pharmacokinetics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Pharmacokinetics Market Share by Regions: 2020 VS 2026
Figure 15. Global Pharmacokinetics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Pharmacokinetics Market Share by Players in 2019
Figure 18. Global Top Pharmacokinetics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacokinetics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Pharmacokinetics Revenue in 2019
Figure 20. North America Pharmacokinetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Pharmacokinetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Pharmacokinetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Pharmacokinetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Pharmacokinetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Pharmacokinetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Pharmacokinetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…- 動物用自己免疫疾患検査の世界市場（～2026年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…
- 希少疾患の世界市場（～2026年） An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases hav…
- POC感染性疾患の世界市場（～2026年） POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted peri…
- 感染症の世界市場（～2026年） When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antip…